Dr. Tracy Minan Frech, MD

Dr. Frech practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Frech's NPI, 1831215227, was assigned on March 21, 2007. Dr. Frech graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2001. Dr. Frech holds Tennessee license 62989.

Dr. Frech's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Frech's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Frech to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frech practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Frech's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Frech is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Frech's licenses on file in 8 states: Tennessee, Utah, Colorado, Idaho, Kentucky, Alabama, Mississippi and Wyoming.

Dmand AI lists lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Frech treats.

CMS data shows 122 Medicare services from Dr. Frech across 2 procedure codes in 2024, for 88 Medicare patients. Medicare paid $7,462 for them.

CMS counts 88 Medicare patients who saw Dr. Frech in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 66% have high cholesterol. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frech's median patient age at 68, with 85% women.

In 2024, Dr. Frech wrote 461 Medicare Part D claims for 69 patients. 92% of them were for generic drugs. CMS names the drug for 360 of them, across 12 drugs with 11 or more claims each, at $249,835 in total drug cost. In 2023, CMS named 272 claims across 10 drugs.

Dr. Frech accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frech as offering telehealth.

Dmand AI links 161 papers to Dr. Frech, published from 2010 to 2025. 2019 was the busiest year, with 18. The most frequent topics are Scleroderma, Systemic, Raynaud Disease and Scleroderma, Diffuse. Dr. Frech has published most often in Clin Exp Rheumatol. Dr. Frech's most frequent co-authors are Dinesh Khanna, MD, Robyn T. Domsic and Shervin Assassi, MD.

Dmand AI links Dr. Frech to 9 clinical trials, 5 of them phase 2 studies. Conditions studied include Scleroderma, Diffuse, Scleroderma, Systemic and Arthritis, Rheumatoid. Corbus Pharmaceuticals Inc. sponsors the most, 2.

CMS Open Payments shows 6 general payments to Dr. Frech from 4 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 92% of the total. Genentech, Inc. paid the most, $4,520.

Dmand AI lists 3 awards for Dr. Frech, most recently CMS Stage 1 EHR in 2013.

Dr. Frech graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2001. Dr. Frech is a member of ACR.

Dr. Frech is in network with 16 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.